Case series of topical 1.5% ruxolitinib cream for pediatric vitiligo

JAAD Case Rep. 2024 Apr 18:54:27-30. doi: 10.1016/j.jdcr.2024.02.034. eCollection 2024 Dec.

Authors

Harry M Meister¹, Mark Lebwohl¹, Nanette Silverberg¹

Affiliation

¹ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Keywords: Janus kinase inhibitors; mixed vitiligo; nonsegmental vitiligo; pediatrics; repigmentation; ruxolitinib; segmental vitiligo; treatment.

Publication types

Case Reports